Literature DB >> 7436444

Erythrocyte transketolase activity in suspected cases of Leigh's disease, or subacute necrotising encephalomyelopathy.

A McBurney, D Leigh, H McIlwain.   

Abstract

Erythrocyte transketolase activity and the effect of adding thiamine pyrophosphate (% thiamine pyrophosphate effect) were measured in 111 subjects suspected to suffer from Leigh's disease (subacute necrotising encephalomyelopathy). From clinical evidence these subjects were divided into five groups: (1) necropsy-proved cases of subacute necrotising encephalomyelopathy, (2) cases positive for urinary thiamine pyrophosphate: adenosine triphosphate phosphotransferase inhibitor, (3) clinically likely cases of subacute necrotising encephalomyelopathy (patients still alive, or on whom no necropsy was performed), (4) cases diagnosed as diseases other than subacute necrotising encephalomyelopathy (control group), (5) cases for which no diagnosis had been made. Comparison of erythrocyte transketolase activities with and without added thiamine pyrophosphate and of the % thiamine pyrophosphate effect for each group compared with the control group showed no statistically significant differences from normal values for any of these parameters. Similarly, there were no differences between the two sexes in transketolase activity, and no correlation between transketolase activity and age. These results indicate that erythrocyte transketolase activity is not altered in subacute necrotising encephalomyelopathy and is unlikely to be of value for the diagnosis of Leigh's disease.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7436444      PMCID: PMC1626908          DOI: 10.1136/adc.55.10.789

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  23 in total

1.  Leigh's encephalomyelopathy: an inborn error of gluconeogenesis.

Authors:  F A Hommes; H A Polman; J D Reerink
Journal:  Arch Dis Child       Date:  1968-08       Impact factor: 3.791

2.  Leigh's subacute necrotizing encephalopathy: clinical and biochemical study, with special reference to therapy with lipoate.

Authors:  B E Clayton; R H Dobbs; A D Patrick
Journal:  Arch Dis Child       Date:  1967-10       Impact factor: 3.791

3.  Restoration by thiamine of the action potential in ultraviolet irradiated nerves.

Authors:  J W Eichenbaum; J R Cooper
Journal:  Brain Res       Date:  1971-09-10       Impact factor: 3.252

4.  Subacute necrotizing encephalomyelopathy. A reappraisal of the thiamine deficiency hypothesis.

Authors:  A H Greenhouse; S A Schneck
Journal:  Neurology       Date:  1968-01       Impact factor: 9.910

5.  Transketolase activity and urinary excretion of thiamin in the assessment of thiamin-nutrition status of Indians.

Authors:  M S Bamji
Journal:  Am J Clin Nutr       Date:  1970-01       Impact factor: 7.045

6.  Experience with phosphoryl transferase inhibition in subacute necrotizing encephalomyelopathy.

Authors:  J R Cooper; J H Pincus; Y Itokawa; K Piros
Journal:  N Engl J Med       Date:  1970-10-08       Impact factor: 91.245

7.  Enzyme-inhibiting factor in subacute necrotizing encephalomyelopathy.

Authors:  J H Pincus; Y Itokawa; J R Cooper
Journal:  Neurology       Date:  1969-09       Impact factor: 9.910

8.  Subacute necrotizing encephalomyelopathy. A review and a study of two families.

Authors:  V J Montpetit; F Andermann; S Carpenter; J S Fawcett; D Zborowska-Sluis; H R Giberson
Journal:  Brain       Date:  1971       Impact factor: 13.501

9.  Thiamine triphosphate deficiency in subacute necrotizing encephalomyelopathy.

Authors:  J R Cooper; Y Itokawa; J H Pincus
Journal:  Science       Date:  1969-04-04       Impact factor: 47.728

10.  A defect in pyruvate decarboxylase in a child with an intermittent movement disorder.

Authors:  J P Blass; J Avigan; B W Uhlendorf
Journal:  J Clin Invest       Date:  1970-03       Impact factor: 14.808

View more
  1 in total

1.  Dystonia as a presenting sign of subacute necrotising encephalomyelopathy in infancy.

Authors:  J Campistol; V Cusi; A Vernet; E Fernandez-Alvarez
Journal:  Eur J Pediatr       Date:  1986-04       Impact factor: 3.183

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.